There are currently 90 clinical trials in Dearborn, Michigan looking for participants to engage in research studies. Trials are conducted at various facilities, including Beaumont Hospital - Dearborn, Oakwood Cancer Center at Oakwood Hospital and Medical Center, Henry Ford Medical Center-Fairlane and Oakwood Hospital and Medical Center. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study
NCT04166318
Recruiting
This phase II trial studies how well lower-dose chemotherapy plus radiation (chemoradiation) therapy works in comparison to standard-dose chemoradiation in treating patients with early-stage anal cancer. Drugs used in chemotherapy, such as mitomycin, fluorouracil, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high-energy x-rays to kill tumor cells... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
06/21/2023
Locations: Henry Ford Medical Center-Fairlane, Dearborn, Michigan
Conditions: Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Canal Squamous Cell Carcinoma, Anal Margin Squamous Cell Carcinoma, Stage I Anal Cancer AJCC v8, Stage IIA Anal Cancer AJCC v8
Register for Updates
Comparing Two Methods to Follow Patients With Pancreatic Cysts
NCT04239573
Recruiting
The purpose of this study is to compare the two approaches for monitoring pancreatic cysts. The study doctors want to compare more frequent monitoring vs less frequent monitoring in order to learn which monitoring method leads to better outcome for patients with pancreatic cysts.
Gender:
All
Ages:
Between 50 years and 75 years
Trial Updated:
06/21/2023
Locations: Beaumont Hospital - Dearborn, Dearborn, Michigan
Conditions: Pancreatic Carcinoma
Register for Updates
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
NCT02201992
Recruiting
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-sma... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
06/20/2023
Locations: Beaumont Hospital - Dearborn, Dearborn, Michigan +1 locations
Conditions: ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, Stage IB Non-Small Cell Lung Carcinoma AJCC v7, Stage II Non-Small Cell Lung Cancer AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7, Stage IIB Non-Small Cell Lung Carcinoma AJCC v7, Stage IIIA Non-Small Cell Lung Cancer AJCC v7
Register for Updates
Battlefield Acupuncture for Pain in Hidradenitis Suppurativa
NCT04218422
Recruiting
The investigators will investigate battlefield acupuncture as a treatment for the pain of hidradenitis suppurativa.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/12/2023
Locations: WSUPG Dermatology, Dearborn, Michigan
Conditions: Hidradenitis Suppurativa
Register for Updates
Preventing Impaired Driving Among Adolescents
NCT04959461
Recruiting
The primary goal of this project is to evaluate the efficacy of webCHAT, a single-session web-intervention, on reducing impaired driving among adolescents receiving behind-the-wheel training at driver education programs.
Gender:
All
Ages:
Between 15 years and 17 years
Trial Updated:
05/04/2023
Locations: DriveSafe Driving School, Dearborn, Michigan
Conditions: Substance-Related Disorders
Register for Updates
Growth Hormone Replacement Therapy for Retried Professional Football Players
NCT04121780
Recruiting
This is a randomized, double-blind, placebo-controlled, parallel-group trial with an open-label extension to evaluate the efficacy of growth hormone (GH) on cognitive functions of retired professional football players with growth hormone deficiency (GHD).
Gender:
Male
Ages:
Between 18 years and 76 years
Trial Updated:
02/06/2023
Locations: Center for Neurolgoical Studies (CNS), Dearborn, Michigan
Conditions: TBI (Traumatic Brain Injury), Concussion, Brain, Sport Injury, Anterior Pituitary Hyposecretion Syndrome, Hypopituitarism, Growth Hormone Deficiency
Register for Updates